Academic Journal
Exploring the Neural Mechanisms of Acupuncture Stimulation in Autism Spectrum Disorder: Protocol for a Randomized, Sham-Controlled, Multimodal Neuroimaging Trial.
| Τίτλος: | Exploring the Neural Mechanisms of Acupuncture Stimulation in Autism Spectrum Disorder: Protocol for a Randomized, Sham-Controlled, Multimodal Neuroimaging Trial. |
|---|---|
| Συγγραφείς: | Sim J; College of Korean Medicine, Sangji University, Wonju-si, Gangwon-do, Republic of Korea., Choi KS; Department of Speech Language Pathology, College of Health Sciences, Sangji University, Wonju-si, Gangwon-do, Republic of Korea., Lee DH; Department of Anatomy, College of Korean Medicine, Sangji University, Sangjidae-gil 83, Wonju-si, Gangwon-do, 26339, Republic of Korea, 82 0337300664.; Research institute of Korean medicine, Sangji University, Wonju-si, Gangwon-do, Republic of Korea. |
| Πηγή: | JMIR research protocols [JMIR Res Protoc] 2026 Oct 15; Vol. 15, pp. e97910. Date of Electronic Publication: 2026 Oct 15. |
| Τύπος έκδοσης: | Clinical Trial Protocol; Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Internet ISSN: 1929-0748 (Electronic) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Toronto : JMIR Publications |
| Ιατρικοί όροι (MeSH): | Acupuncture Therapy*/methods , Autism Spectrum Disorder*/therapy , Autism Spectrum Disorder*/physiopathology , Autism Spectrum Disorder*/diagnostic imaging , Neuroimaging*/methods, Brain/diagnostic imaging ; Brain/physiopathology ; Multimodal Imaging/methods ; Adolescent ; Child ; Female ; Humans ; Male ; Randomized Controlled Trials as Topic |
| Περίληψη: | Background: Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by restricted and repetitive behaviors and disturbances in social communication and interaction. Currently, there is no fundamental treatment for ASD, with only a few medications available for use on a limited basis to manage concomitant neuropsychiatric symptoms. The primary therapeutic goal of such treatments is to alleviate symptoms while maximizing the functional independence and quality of life of affected individuals. Many complementary and alternative medicine therapies have been reported to have effects on ASD symptoms; however, evidence is insufficient to confirm their clinical effectiveness. Acupuncture has traditionally been used as a complementary intervention to manage various neurological and neuropsychiatric diseases, including ASD, in East Asia. However, how acupuncture stimulation modulates neural activity at the macroscale level in individuals with ASD remains largely unknown. Objective: This study aims to elucidate disease-related brain alterations and explore the acute neural mechanisms underlying acupuncture stimulation in patients with ASD and in typically developing (TD) individuals, using a multimodal neuroimaging approach. Methods: This study was designed as a randomized, sham-controlled trial. In this stratified 2×2 design, 70 participants, including individuals with ASD (n=35) and TD controls (n=35), will each be randomly assigned to either the verum or sham acupuncture group, resulting in 4 groups. The verum acupuncture group will receive stimulation at specific acupoints clinically indicated for ASD, eliciting a deqi sensation. The sham acupuncture group will receive superficial needling at nonacupoints unrelated to ASD symptoms. Each group will undergo clinical assessments and multimodal neuroimaging measurements, including functional near-infrared spectroscopy and electroencephalography, before and after acupuncture stimulation. The primary outcome will be differences in resting state network metrics and relative band power in frontal areas by disease status. Secondary outcomes will include differences in these neural markers following acupuncture stimulation between the verum and sham groups, reflecting the group × intervention interaction. Exploratory outcomes will focus on identifying neural markers that correlate with clinical indicators of ASD. Results: Recruitment began in April 2025. To date, 23 individuals with ASD and 21 TD individuals have participated in this study. The recruitment process is expected to continue until December 2026. Conclusions: ASD presents a significant socioeconomic burden, with no definitive treatment established to date. Although acupuncture is a widely applied intervention for various neurological conditions, including ASD, its large-scale neural mechanisms remain poorly understood. By using multimodal neuroimaging, the present study aims to investigate the immediate neural substrates underlying acupuncture stimulation in patients with ASD. These findings are expected to provide a robust neurobiological foundation for future longitudinal research and the development of evidence-based integrative strategies. (© Jaehee Sim, Koung-soon Choi, Dong Hyuk Lee. Originally published in JMIR Research Protocols (https://www.researchprotocols.org).) |
| References: | Psychiatry Investig. 2020 May;17(5):432-443. (PMID: 32375461) Transl Psychiatry. 2025 Oct 24;15(1):428. (PMID: 41136355) Mol Autism. 2022 May 18;13(1):22. (PMID: 35585637) Brain Stimul. 2023 Mar-Apr;16(2):567-593. (PMID: 36828303) Hum Brain Mapp. 2024 Feb 1;45(2):e26619. (PMID: 38339822) Lancet. 2018 Aug 11;392(10146):508-520. (PMID: 30078460) Neuropsychiatr Dis Treat. 2023 Apr 18;19:951-972. (PMID: 37096024) Comput Intell Neurosci. 2011;2011:130714. (PMID: 21687590) Front Psychiatry. 2023 May 25;14:942069. (PMID: 37304438) BMJ Evid Based Med. 2023 Feb;28(1):7-14. (PMID: 35101925) Lancet Neurol. 2015 Nov;14(11):1121-34. (PMID: 25891007) BMJ. 2020 Mar 25;368:m697. (PMID: 32213509) Sovrem Tekhnologii Med. 2025;17(2):73-83. (PMID: 40416500) Altern Med Rev. 2010 Jul;15(2):136-46. (PMID: 20806998) Psychiatry Clin Neurosci. 2017 Oct;71(10):725-732. (PMID: 28547882) Neuroimage. 2014 Jan 15;85 Pt 1:1-5. (PMID: 24321364) Clin Psychol Rev. 2010 Jun;30(4):387-99. (PMID: 20223569) Evid Based Complement Alternat Med. 2018 Jan 11;2018:1057539. (PMID: 29552077) Front Neurol. 2024 Apr 16;15:1327206. (PMID: 38689877) Autism Res. 2019 Apr;12(4):600-613. (PMID: 30758144) Int J Psychophysiol. 2019 Mar;137:41-53. (PMID: 30664885) Neurosci Biobehav Rev. 2012 Apr;36(4):1292-313. (PMID: 22353426) Psychiatry Investig. 2021 Sep;18(9):831-840. (PMID: 34500507) J Acupunct Meridian Stud. 2022 Dec 31;15(6):333-335. (PMID: 36537115) Front Public Health. 2025 Oct 16;13:1681565. (PMID: 41179783) Front Aging Neurosci. 2025 Jan 08;16:1468246. (PMID: 39845444) Chin Med. 2018 Jun 15;13:30. (PMID: 29983730) BMJ. 2013 Jan 08;346:e7586. (PMID: 23303884) Res Autism Spectr Disord. 2015 Sep 1;17:40-51. (PMID: 26366192) Medicine (Baltimore). 2026 Jan 09;105(2):e46851. (PMID: 41517678) Front Hum Neurosci. 2021 Jun 15;15:643410. (PMID: 34211379) Psychol Med. 2015 Feb;45(3):601-13. (PMID: 25108395) Transl Psychiatry. 2023 Dec 14;13(1):389. (PMID: 38097538) Neurotherapeutics. 2022 Jan;19(1):248-262. (PMID: 35029811) J Autism Dev Disord. 2025 Nov;55(11):4068-4080. (PMID: 39102070) Biol Psychiatry. 2013 Aug 1;74(3):212-9. (PMID: 23375976) Medicine (Baltimore). 2023 Nov 17;102(46):e35275. (PMID: 37986368) J Autism Dev Disord. 2006 Oct;36(7):901-9. (PMID: 16897395) Transl Pediatr. 2020 Feb;9(Suppl 1):S55-S65. (PMID: 32206584) Clin Psychol Rev. 2013 Dec;33(8):940-53. (PMID: 23988454) Ann Rehabil Med. 2019 Jun;43(3):279-288. (PMID: 31311249) Biomed Opt Express. 2014 Mar 27;5(4):1262-74. (PMID: 24761305) Health Psychol Res. 2024 Sep 21;12:123439. (PMID: 39944713) Am J Intellect Dev Disabil. 2009 Jan;114(1):23-41. (PMID: 19143460) Nat Commun. 2020 Aug 7;11(1):3959. (PMID: 32770077) Complement Ther Med. 2011 Jan;19 Suppl 1:S41-8. (PMID: 21195294) Psychiatry Res. 2024 Sep;339:116040. (PMID: 38901364) |
| Contributed Indexing: | Keywords: EEG; acupuncture; autism spectrum disorder; brain connectivity; electroencephalogram; fNIRS; functional near-infrared spectroscopy; multimodal imaging; neural mechanism; neuroimaging; randomized controlled trial |
| Entry Date(s): | Date Created: 20261009 Date Completed: 20261009 Latest Revision: 20261016 |
| Update Code: | 20261016 |
| PubMed Central ID: | PMC13650554 |
| DOI: | 10.2196/97910 |
| PMID: | 42852593 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1929-0748 |
|---|---|
| DOI: | 10.2196/97910 |